N-hydroxysulfosuccimide,
sulfo-NHS,
N-Hydroxysulfosuccinimide sodium salt,
106627-54-7,
Sulfo-NHS,
sodium 1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate,
N-hydroxysulfosuccinimide,sodium salt,
MFCD00043100,
AK-44462,
N-Hydroxysulfosuccinimidesodiumsalt,
3-Pyrrolidinesulfonic acid, 1-hydroxy-2,5-dioxo-, monosodium salt,
N-Hydroxysulfosuccinimide sodium salt, 95%,
C4H4NNaO6S,
AC1MRMX7,
SCHEMBL303254,
Sodium 1-hydroxy-2,5-dioxo-pyrrolidine-3-sulfonate,
N-Hydroxusulfosuccinimide sodium,
DTXSID00393267,
RPENMORRBUTCPR-UHFFFAOYSA-M,
KS-00000C8F,
ZX-RL005771,
N-Hydroxy-2-(sodiosulfo)succinimide,
CS-024,
N-Hydroxusulfosuccinimide sodium salt,
AKOS015897304,
N-Hydroxysulfosuccinimide, sodium salt,
AM83858,
CS-W002213,
LS41951,
RL00288,
AC-24882,
AN-33832,
AS-17664,
BP-20409,
BP-22664,
BR-44462,
OR307159,
SC-11273,
SY019057,
AB0020381,
AB1011494,
AX8030082,
TR-001318,
FT-0658199,
ST24033285,
V1233,
M-1988,
MFCD00043100 (95+%),
Sodium 1-hydroxy-2,5-dioxo-3-pyrrolidinesulfonate,
sodium,1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate,
3-Pyrrolidinesulfonic acid, 1-hydroxy-2,5-dioxo-,,
I09-0590,
J-200322,
J-523593,
N-Hydroxysulfosuccinimide sodium salt, >=98% (HPLC),
hydroxy-2,5-dioxopyrrolidine-3-sulfonic acid sodium salt,
Hydroxy-2,5-dioxopyrrolidine-3-sulfonicacid sodium salt,
1-Hydroxy-2,5-dioxo-pyrrolidine-3-sulfonic acid sodiuM salt,
Hydroxy-2,5-dioxopyrrolidine-3-sulfonicacid sodium salt; Sulfo-NHS,
LYSOZYME,
ACN-029999,
CID3520574,
CID6099484,
H1304,
S-5153,
N-Hydroxysulfosuccinimide sodium salt, 97% 250mg,
N-Hydroxysulfosuccinimide sodium salt, 98% - 1G 1g,